by | Apr 19, 2024 | Lupus Foundation of America, News & Events
The U.S. Food & Drug Administration has granted approval for a Phase 1 study to evaluate the safety and efficacy of investigational therapy, CB-010, for treatment of lupus nephritis (LN). The GALLOP study will begin by year-end and will also be evaluated for...
by | Apr 17, 2024 | Lupus Foundation of America, News & Events
Understanding the immune cells that spur inflammation in lupus nephritis (LN) can help advance knowledge of disease progression and identify new treatments. A new study discovered that macrophages, a type of white blood cells that attack and destroy diseased and...
by | Apr 11, 2024 | Lupus Foundation of America, News & Events
Incorporating physical activity and exercise can help improve health outcomes and quality of life for people living with systemic lupus erythematosus (SLE). Recently, an international task force provided the first set of recommendations for physical activity that...
by | Apr 5, 2024 | Lupus Foundation of America
Karleen’s journey with lupus began in the summer of 1983 when she received her lupus diagnosis, although her symptoms first began appearing as early as 1982 during her freshman year of college. Mouth sores and knee swelling were the initial signs, gradually...
by | Apr 5, 2024 | Lupus Foundation of America, News & Events
A new study examined the relationship between race and the plasma microbiome, or gut matter, in people with lupus. Researchers discovered racial differences in the plasma and identified specific plasma microbiome differences associated with systemic lupus...
by | Apr 4, 2024 | Lupus Foundation of America
This May during Lupus Awareness Month, lupus advocates from across the country will unite on Capitol Hill to make lupus a priority on the national health agenda. Join us in Washington, DC for the National Lupus Advocacy Summit, the nation’s largest lupus...